Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cartesian Therapeutics (RNAC) Long-Term Investments: 2015-2025

Historic Long-Term Investments for Cartesian Therapeutics (RNAC) over the last 8 years, with Sep 2025 value amounting to $2.0 million.

  • Cartesian Therapeutics' Long-Term Investments changed negligibly% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $2.0 million for FY2024, which is negligibly% changed negligibly from last year.
  • According to the latest figures from Q3 2025, Cartesian Therapeutics' Long-Term Investments is $2.0 million, which was down 0.00% from $2.0 million recorded in Q2 2025.
  • In the past 5 years, Cartesian Therapeutics' Long-Term Investments registered a high of $2.0 million during Q3 2021, and its lowest value of $2.0 million during Q3 2021.
  • Over the past 3 years, Cartesian Therapeutics' median Long-Term Investments value was $2.0 million (recorded in 2025), while the average stood at $2.0 million.
  • Data for Cartesian Therapeutics' Long-Term Investments shows a peak YoY surged of 45.03% (in 2021) over the last 5 years.
  • Over the past 5 years, Cartesian Therapeutics' Long-Term Investments (Quarterly) stood at $2.0 million in 2021, then remained steady at $2.0 million in 2022, then remained steady at $2.0 million in 2023, then remained steady at $2.0 million in 2024, then remained steady at $2.0 million in 2025.
  • Its Long-Term Investments stands at $2.0 million for Q3 2025, versus $2.0 million for Q2 2025 and $2.0 million for Q1 2025.